← FDA Drug Approvals (Drugs@FDA)
PRIFTIN
NDA · New Drug Application · Sponsor: SANOFI AVENTIS US · Approved 1998-06-22
Drug application
- FDA Application #
NDA021024- Application type
- New Drug Application
- Brand name
- PRIFTIN
- Generic name
- RIFAPENTINE
- Active ingredients
- RIFAPENTINE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- SANOFI AVENTIS US
- Manufacturer
- sanofi-aventis U.S. LLC
- First approval
- 1998-06-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown